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INTRODUCTION
Female sexual function is affected by various fac-
tors, including sex hormones (estrogen, androgen,
and progesterone) that have different effects on
vaginal tissue and the central nervous system. Oral
Estrogen increases Sex Hormone Binding Globulin
(SHBG). SHBG is a protein that transport sexual
hormone in the liver, which can increase or de-
crease, according to its androgen and anti-andro-
genic properties. Testosterone has a high affinity
for SHBG, and high SHBG levels can reduce levels
of free testosterone, which is important for sexual
function.1
It is suggested that there is a relationship bet-
ween the combined oral contraceptive pill and sex-
ual dysfunction, although the effect of combined
Abstract
Objectives: The aim of this research was to assess the relationship
between total testosterone level and female sexual function based
on Female Sexual Function Index (FSFI) among the acceptors of
combined oral contraceptive pill.
Methods: The research was conducted in BLU of Dr. Wahidin Sudi-
rohusodo Hospital and several teaching hospitals in obstetrics and
gynecology sections of Medical faculty, Hasanuddin University from
October to December 2012. This study assessed sexual function
among 60 women as the acceptors of combined oral contraceptive
pill. Sexual function was assessed using FSFI questionnaire which
had been validated in several countries. This research used cross
sectional design and the sample was selected using consecutive sam-
pling method. The data were processed using SPSS with inde-
pendent t test of the significant level of 0.05. 
Results: The results of the research reveal that total testosterone
level among the acceptors of combined oral contraceptive pill who
have impaired sexual function is low. The result of the correlation
test between testosterone level and FSFI score indicates a significant
level (p<0.05) with a correlation coefficient of (r) = 0.737. The tes-
tosterone level of female who have impaired sexual function is sig-
nificantly different (p<0.05) from women who have normal sexual
function. The cut off testosterone level that could indicate the occur-
rence of sexual dysfunction is 12.4 ng/dl.
Conclusion: The total testosterone level among the acceptors of
combined oral contraceptive pill who have impaired sexual function
is lower than others who have no impaired sexual function.
[Indones J Obstet Gynecol 2013; 1-3: 129-33]
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Abstrak
Tujuan: Penelitian ini bertujuan menilai hubungan kadar testosteron
total dengan fungsi seksual perempuan berdasarkan female sexual
function index (FSFI) pada akseptor pil KB kombinasi.
Metode: Penelitian ini dilakukan di BLU Rumah Sakit Dr. Wahidin
Sudirohusodo dan beberapa rumah sakit pendidikan bagian obstetrik
dan ginekologi Fakultas Kedokteran Unhas selama Oktober sampai
dengan Desember 2012. Sampel penelitian sebanyak 60 orang aksep-
tor pil KB kombinasi. Pengambilan sampel dilakukan secara consecu-
tive sampling. Penilaian fungsi seksual dilakukan dengan kuesioner
FSFI yang telah divalidasi di beberapa negara dengan metode potong
lintang (cross sectional). Pengolahan data menggunakan SPSS versi
16 melalui independent t-Test dengan tingkat signifikansi 0.05.
Hasil: Hasil penelitian menunjukkan bahwa kadar testosteron total
pada akseptor pil KB kombinasi yang fungsi seksualnya terganggu
adalah rendah. Hasil uji korelasi antara kadar testosteron dengan
skor FSFI menunjukkan korelasi bermakna (p<0.05) dengan koefisien
korelasi (r) = 0.737. Kadar testosteron perempuan yang terganggu
fungsi seksualnya berbeda secara bermakna (p<0.05) dengan perem-
puan yang tidak terganggu fungsi seksualnya. Cut off kadar testoste-
ron yang dapat menunjukkan terjadinya gangguan fungsi seksual,
yaitu, 12,4 ng/dl.
Kesimpulan: Kadar testosteron total pada akseptor pil KB kombinasi
yang fungsi seksualnya terganggu adalah lebih rendah dban-dingkan
dengan yang tidak terganggu fungsi seksualnya.
[Maj Obstet Ginekol Indones 2013; 1-3: 129-33]
Kata kunci: akseptor pil KB kombinasi, FSFI, fungsi seksual, kadar
testosteron total
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oral contraceptive pill is still unclear. Birth control
pills contain a combination of estrogen ethinyles-
tradiol (EE) and the synthetic progestin that can
affect serum levels of SHBG and also can potentially
affect the female sexual function.2-5
Graham et al in 2007 examined the serum levels
of total testosterone, free testosterone, dehydro-
epiandrosterone sulfate among user of progestin
combined oral contraceptive pill. Significant de-
crease has been shown in 3 months.6 They also
found that there is a correlation between a low
level of total testosterone, free testosterone levels
and sexual desire. However, some women who
have low testosterone levels show no impairment
on sexual desires among them. Thus, the authors
concluded that some women may be more sensi-
tive to changes in testosterone levels. Serum levels
of free testosterone after the use of 25 and 35 μg
EE and other progestin have been studied by Greco
et al in 2007. Greco found that a low dose of EE
associated with a smaller decline of free testoster-
one. Two recent research studying the effects of
oral contraceptives on serum SHBG levels and the
possible correlation with sexual function.7 Panzer
et al examined 124 serum levels in women with
sexual dysfunction who use and do not use combi-
nation oral contraceptives.8 SHBG levels increased
four times higher among users, and FSFI scores
(Female Sexual Function Index) was also lower.
Warnock et al measured SHBG, total testosterone
and free testosterone levels in 106 women with
sexual dysfunction, 43 of them is the user of com-
bined oral contraceptive pill. The levels of total
SHBG and free testosterone levels were lower
among non-users compared among user, but both
suffered sexual function disorders.6-9
Female Sexual Function Index (FSFI) is a valid
and accurate measurement of female sexual func-
tion. The questionnaire consisted of 19 questions
divided into six sub score, including sexual desire,
arousal, lubrication, orgasm, satisfaction, and
pain.10 FSFI is used to measure sexual function in-
cluding sexual desire in the last 4 weeks. High
scores on each level domain showed better sexual
function.11
Based on the formulation of the theory and
some of the above studies, there is a strong need
to conduct a study which assessed the relationship
between total testosterone levels with sexual func-
tion among the user of combination oral contra-
ceptive. Thus it can be used as consideration for
the provision of counseling, information and edu-
cation about relationships between pill combina-
tions and female sexual function.
METHODS
Location and Research Design
The research was carried out in several teaching
hospital in Obstetrics and Gynecology of Hasanud-
din University Makassar as well as Dr. Wahidin
Sudirohusodo hospital and its networks. The study
was conducted from October 2012 to December
2012. Research design used in this study is cross-
sectional which aims to determine the effect of
combined oral contraceptive pill in changing total
testosterone levels and the sexual function of
women.
Population and Sample
The population in this study is the combined oral
contraceptive pill acceptors in Dr. Wahidin Sudiro-
husodo hospital in and its networks in department
of Obstetrics and Gynecology in Makassar. Samples
were new acceptors of combination tablets that
have signed informed consent. They were taken in
accordance with the inclusion and exclusion crite-
ria. Minimum sample size in this study was calcu-
lated based on the formula test of correlation be-
tween the two variables which obtained as many
as 60 people.
Inclusion criteria for this sample were primi-
parous, aged between 20-35 years, not pregnant or
breast-feeding, new acceptors combined oral con-
traceptive pill and not using hormonal birth con-
trol method before, body mass index (BMI) normal
18.5 to 23 kg/m2, have no a contraindication to
hormonal contraception, do not suffer from chro-
nic diseases, living with her husband, did not give
birth with vacuum extraction/forceps, episiotomy
is not performed at the time of birth, not taking
medication or a supplement for weight loss drugs
that alter lipid profiles such as anti-cholesterol
drugs and anti diabetic drugs, no alcohol, no his-
tory of sexual trauma and filling Informed Consent.
Exclusion criteria were subjects withdrew from the
study or drops out during the study period or
changes the way or method of family planning.
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Processing and Presentation of Data
Processing and analyzing the data is using a statis-
tical program. Data analysis includes descriptive
part which calculate the amount and determine the
percentage, and analysis using statistical test of
Pearson correlation test and independent t-test
with significance level of p <0.05 has been done.
RESULTS
Sample is obtained as much as 60 people, aged 20-
33 years with a mean (SD) = 24.5 (3.3) years. Du-
ration of acceptor 6-20 months with a mean (SD)
= 11.1 (3.3) months. Testosterone levels vary
widely, ranging from 2.4 to 61.3 ng/ml with a mean
(SD) = 14.53 (11.92) ng/dl; while FSFI scores var-
ied between 12.2 to 33.1 with a mean (SD ) = 24.69
(4.64), (Table 1)
Table 1. Variable Description
Variable
Descriptive statistics
Data
Distributionn Minimal/
Maximum
Mean (SD)
Age (years) 60 20/33 25.4 (3.3) Normal
Duration of acceptor
(month)
60 6/20 11.1 (3.3) Abnormal
Testosteron’s level
(ng/dl)
60 2.4/61.3 14.53 (11.92) Normal
FSFI 60 12,2/33.1 24.69(4.6) Normal
Multivariate analysis
Pearson correlation which used to test the FSFI and
total testosterone levels showed significant corre-
lation (p < 0.05) with a correlation coefficient (r)
= 0.737. Total testosterone, age and no longer be
acceptors has a significant correlation (p > 0,05).
The lower total testosterone levels, the lower the
value of FSFI (Table 2).
Table 2. The Correlation of Age, Duration of Acceptor,
Testosteron’s Level and FSFI
Variable 
Correlation
Testosteron’s  Level
The Correlation Coef-
ficient ( r ) Pearson
Significance
(p)
Age (year) r = - 0.030 p=0.409
Duration of acceptor
(year)
r = - 0,046 p=0.363
FSFI r = 0.737 p=0.000
FSFI score = 26.55 interpreted have disturbed
sexual function, the analysis of independent t test
showed that total testosterone levels who have im-
paired sexual function was significantly different
(p < 0.05) with a group who has no sexual function.
Testosterone levels in those with impaired smaller
than the normal group. Age showed no significant
difference in statistics (p > 0.05); (Table 3).
Table 3 showed the cut off testosterone levels
which showed the occurrence of sexual dysfunc-
tion; namely: 12.4 ng/dl. That is, if levels < 12.4
ng/dl can predict sexual interference. Based on the
minimum value of the group who have no impaired
sexual function (12.4 ng/dl), the levels < 12.4 ng/dl
showed none of whom still have normal sexual
function. Even, among people who have total tes-
tosterone levels from 12.4 to 14.74 ng/dl, there are
still individuals who experience sexual dysfunction.
Total testosterone levels > 14.74 ng/dl usually do
not experience sexual dysfunction.
Table 3. Differences in Age, Duration of Acceptor and Testosterone Levels between the Groups without Sexual Dysfunction.
Variable
Sexual Disfunction
Independent
t-test
Yes (n=31) No (n=29)
Min/Max Mean(SD) Min/Max Mean(SD)
Age (years) 20/33 25.1(3.0) 20/32 25.7(3.7) p=0.497
Duration of acceptor (month) 6/17 11.1(3.1) 6/20 11.1(3.5) p=0.974
Testosteron’s level (ng/dl) 2.4/14.74 6.31 (3.58) 12.4/61.3 23.31 (11.44) p=0.000
Information: ROC curve showed a cut-off = 12.4 with AUC = 99.3%
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Figure 1 shows the difference in testosterone
levels between the groups with impaired sexual
function and the group who has no impaired sexual
function. Total testosterone levels (mean and 95%
CI) in those with impaired sexual function are
lower than the group without sexual dysfunction.
DISCUSSION
This study showed that a total testosterone level
in the combined oral contraceptive pill acceptors
who has impaired sexual function is low. Sexual
function is dynamic and it is influenced by changes
throughout life transitions, such as first sexual in-
tercourse, pregnancy, children, and partner. Age ul-
timately affects the sexual function of a women
through processes such as menopause and health
decline along with the increasing age 12. Age is bi-
ased with duration of having relationship and num-
ber of children. With age, the quality of the rela-
tionship and the mount of children will be more.
Duration as an acceptor 6-20 months with a
mean (SD) = 11.1(3.3) months. Testosterone levels
are very varied, ranging from 2.4 to 61.3 ng/ml
with a mean (SD) = 14.53(11.92) ng/dl; while FSFI
scores varied between 12.2 to 33.1 with a mean
(SD ) = 24.69(4,64). Graham et al examined the se-
rum levels of total testosterone, free testosterone,
dehydroepiandrosterone sulfate during the use of
oral contraceptives that use same progestin. A sig-
nificant reduction was obtained after 3 months.
They found also that there is a statistical correla-
tion between low total testosterone and free tes-
tosterone levels as well as frequency of sexual de-
sire. However, some women showed no loss of sex-
ual function despite low testosterone levels.
Results of correlation between testosterone lev-
els and FSFI showed significant correlation (p <
0.05) with a correlation coefficient (r) = 0.737. The
correlation of testosterone level with age and du-
ration as an acceptor was shown to have no a sig-
nificant correlation (p > 0.05). The lower levels of
testosterone, the lower the value FSFI. Warnock et
al measured levels of total testosterone, SHBG, and
free testosterone levels in 106 women with im-
paired sexual function, 43 of them are combined
oral contraceptive pill acceptors. Among the com-
bined oral contraceptive pill acceptors, higher lev-
els of SHBG and total as well as free testosterone
levels is lower than non-acceptors, but they expe-
rience sexual dysfunction.
FSFI score = 26.55 declared as having impaired
sexual function, the independent t test analysis
found that testosterone levels among women who
has impaired sexual function and their counter-
parts was statistically significant (p < 0.05). Testos-
terone levels in those with impaired sexual func-
tion are smaller than their counterparts. The age
showed no significant difference (p > 0.05). Serum
levels of free testosterone with the use of 25 and
35 mcg ethinylestradiol and same progestin has
been investigated by Greco et al in 2007.7 They
found that low doses of ethinylestradiol were as-
sociated with a lesser decline of free testosterone.
Panzer et al examined 124 serum levels in women
with decreased sexual function who did and did
not use oral contraception. SHBG levels increased
four times higher in the women using oral contra-
ception, and FSFI scores were also lower.8
CONCLUSIONS
We conclude that total testosterone levels were
lower among the combined oral contraceptive pill
acceptors. The lower total testosterone levels, the
lower FSFI scores. Cut off value of testosterone lev-
els showed that the occurrence of sexual dysfunc-
tion; namely: 12.4 ng/dl. As a suggestion, the fur-
ther research is needed especially with more num-
ber of samples. There is a strong need to get
knowledgeable health care provider who can pro-
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Figure 1. Differences in testosterone levels between
groups of impaired sexual function and normal sex
function.
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vide education and counseling on sexual function
and sexual activity in particular about family plan-
ning the candidates of combined oral contraceptive
pill acceptor.
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